W. D. Venon

Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2

M. Rizzetto, M. Fadda, C. Alessandria, 2002, European journal of gastroenterology & hepatology.

Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study.

M. Rizzetto, G. Saracco, M. Fadda, 2003, Journal of hepatology.

Transcatheter arterial chemoembolization for hepatocellular carcinoma in cirrhosis: influence on portal hypertension

F. Brunello, M. Rizzetto, G. Saracco, 2011, European journal of gastroenterology & hepatology.

Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment

M. Rizzetto, M. Fadda, C. Alessandria, 2004, European journal of gastroenterology & hepatology.

ENDOSCOPIC VARICEAL LIGATION FOR PROPHYLAXIS OF ESOPHAGEAL VARICEAL BLEEDING: TECHNICAL ASPECTS AND OUTCOME

M. Rizzetto, M. Bruno, G. Saracco, 2009 .

4756 Eus can supply information of clinical usefulness and prognostic value in evaluating patients with portal hypertension (ph).

C. Angelis, M. Rizzetto, A. Repici, 2000 .

4532 Clinical application of endoscopic ultrasound in portal hypertension: eus can predict variceal recurrence in endoscopically treated patients.

C. Angelis, M. Rizzetto, A. Repici, 2000 .

Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: Comparison with propranolol in a randomised controlled study

M. Rizzetto, G. Saracco, M. Fadda, 2001 .